Conference Coverage

James Matera, MD, on Post-CRS 2018: BP, Kidney Disease, and Cardiometabolic Risk

09/01/2018

Dr. James Matera explains the impact of hypertension, chronic kidney disease, and end-stage renal disease on cardiometabolic risk — topics he discussed in his presentation, "Addressing Your Patient's Cardiometabolic Risk: Management of Complex Hypertension Cases - Part Three," at the 2018 Cardiometabolic Risk Summit in San Antonio, TX.

For more CRS 2018 coverage, visit our Conference Page.

Related Content

Medication Prescribing
Medication Prescribing
Antonio Anzueto, MD, on Single-Inhaler Triple Therapy Compared With Monotherapy In COPD
01/15/2021
In this video, Antonio Anzueto, MD, gives an overview of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among patients with symptomatic COPD,...
01/15/2021
Neurology
Neurology
Expert Insights in Neurology: Dawn Buse, PhD, on the OVERCOME Study
05/19/2020
In this video, Dr Buse discusses the findings of the OVERCOME Study, in which she and her colleagues investigated the influence of acute treatment optimization on disability and health-related quality of...
05/19/2020
Pediatric Rheumatology
Pediatric Rheumatology
Karen Onel, MD, on A Preview of the ACR Guideline for the Management of JIA
12/01/2020
In this video, Karen Onel, MD, previews the ACR guideline for the management of juvenile idiopathic arthritis, which addresses treatments for systemic JIA, oligoarthritis, and TMJ arthritis.
12/01/2020
Hair Loss
brett a king dermatology
Hair Loss
Brett A. King, MD, PhD, on Whether Topical JAK Inhibitors Work
08/10/2017
In this video, Dr Brett A. King from Yale School of Medicine talks about what JAK inhibitors are, their adverse effect profile, and more.
08/10/2017
Inflammatory Bowel Disease
Hanauer
Inflammatory Bowel Disease
Stephen Hanauer, MD, on Positioning JAK Inhibitors in IBD
07/25/2020
He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.
07/25/2020